{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:01:08Z","timestamp":1790632868312,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>Metabolic-associated steatotic liver disease (MASLD) is a growing global health concern. Although several studies have demonstrated associations between baseline metabolic factors and hepatic steatosis, the quantitative influence of these characteristics on the extent of liver fat reduction following lifestyle modification remains unclear. This study aims to analyse the relationship between baseline factors and the modulation of controlled attenuation parameter (CAP) from baseline to 6 months and compare the mean difference in CAP changes of individuals at a telemedicine-based clinic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cohort of MASLD who had hepatic steatosis (CAP\u2009\u2265\u2009215 dB\/m) with metabolic risk were enrolled. (30 August 2023\u201330 April 2024). Baseline characteristics, diet and exercise were collected. Multivariable multilevel random intercepts and slope linear regression models were used to analyse the mean difference in CAP change over time for each characteristic adjusted for other variables in the model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age was 46.93 years, 70% were females. The baseline CAP value was 319.13\u2009\u00b1\u200942.33 dB\/m. Individual baseline age\u2009\u2265\u200945 (\u221244.52 dB\/m [CI \u221284.86 to \u22124.17], p\u2009=\u20090.031); higher waist circumference (\u221287.85 dB\/m [CI \u2212153.23 to \u221222.47], p\u2009=\u20090.008); and a lower BMI (\u221278.31 dB\/m [CI \u2212139.94 to \u221216.67], p\u2009=\u20090.013) were associated with greater reductions in the mean difference of CAP change. Notably, participants with diabetes (\u221261.31 dB\/m [CI \u2212100.25 to \u221222.36], p\u2009=\u20090.002) and better glycemic control (\u221243.49 dB\/m [CI \u221274.00 to \u221212.99], p\u2009=\u20090.005) exhibited greater liver fat reductions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lifestyle modification led to significant reductions in liver fat, and the extent of improvement was influenced by baseline metabolic characteristics. These findings suggest that metabolic profiles, rather than weight loss alone, determine treatment responsiveness and support the use of individualized lifestyle strategies for MASLD management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0336294","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:31:41Z","timestamp":1764786701000},"page":"e0336294","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Vajira Hospital"],"prefix":"10.1371","volume":"20","author":[{"given":"Sonsawan","family":"Sangprasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratchaneewan","family":"Kwancharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witchakorn","family":"Ruamtawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-3669","authenticated-orcid":true,"given":"Supatsri","family":"Sethasine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"2","key":"pone.0336294.ref001","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"H Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0336294.ref002","article-title":"Estimated Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in US Adults, 2020 to 2050","volume":"8","author":"P Le","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"10","key":"pone.0336294.ref003","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1080\/00365521.2023.2209686","article-title":"Real world for management of hepatocellular carcinoma: a large population-based study","volume":"58","author":"S Sethasine","year":"2023","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"pone.0336294.ref004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-097114","article-title":"Association between glucose intolerance and fatty liver disease in women with previous gestational diabetes mellitus in urban Thailand: a prospective cohort study","volume":"15","author":"C Phaloprakarn","year":"2025","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0336294.ref005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13006-024-00684-3","article-title":"Relationship between breastfeeding and hepatic steatosis in women with previous gestational diabetes mellitus","volume":"19","author":"S Sethasine","year":"2024","journal-title":"Int Breastfeed J"},{"key":"pone.0336294.ref006","doi-asserted-by":"crossref","first-page":"110860","DOI":"10.1016\/j.contraception.2025.110860","article-title":"Contraception and nonalcoholic fatty liver disease in women with prior gestational diabetes mellitus","volume":"145","author":"S Sethasine","year":"2025","journal-title":"Contraception"},{"issue":"20","key":"pone.0336294.ref007","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.3390\/ijms242015473","article-title":"Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments","volume":"24","author":"H Yanai","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0336294.ref008","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2024","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0336294.ref009","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"M Eslam","year":"2020","journal-title":"Hepatol Int"},{"issue":"7","key":"pone.0336294.ref010","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jgh.12557","article-title":"Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease","volume":"29","author":"W-K Chan","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"pone.0336294.ref011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-019-0961-9","article-title":"Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"19","author":"K Pu","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"pone.0336294.ref012","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12916-025-04320-7","article-title":"Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"VA Arita","year":"2025","journal-title":"BMC Med"},{"issue":"2","key":"pone.0336294.ref013","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/apt.70174","article-title":"Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Population-Based Cohort Study","volume":"62","author":"YH Yeo","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"pone.0336294.ref014","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00423-024-03600-9","article-title":"A hypocaloric protein-rich diet before metabolic surgery improves liver function in patients with obesity and diabetes\u00a0: A secondary analysis of a randomized clinical trial","volume":"410","author":"N Kr\u00f6nert","year":"2025","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"pone.0336294.ref015","doi-asserted-by":"crossref","first-page":"100488","DOI":"10.1016\/j.bpsgos.2025.100488","article-title":"Mediation Analyses Link Cardiometabolic Factors and Liver Fat With White Matter Hyperintensities and Cognitive Performance: A UK Biobank Study","volume":"5","author":"DE Askeland-Gjerde","year":"2025","journal-title":"Biol Psychiatry Glob Open Sci"},{"issue":"6","key":"pone.0336294.ref016","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2012.02820.x","article-title":"Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography","volume":"32","author":"V de L\u00e9dinghen","year":"2012","journal-title":"Liver Int"},{"issue":"4","key":"pone.0336294.ref017","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"P Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"pone.0336294.ref018","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"European Association for the Study of the Liver","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0336294.ref019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/liv.14669","article-title":"Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review","volume":"41","author":"J Lee","year":"2021","journal-title":"Liver Int"},{"issue":"5","key":"pone.0336294.ref020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/00913847.1985.11708790","article-title":"Practical Assessment of Body Composition","volume":"13","author":"AS Jackson","year":"1985","journal-title":"Phys Sportsmed"},{"issue":"5","key":"pone.0336294.ref021","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1152\/jappl.1985.58.5.1565","article-title":"Estimation of human body composition by electrical impedance methods: a comparative study","volume":"58","author":"KR Segal","year":"1985","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"pone.0336294.ref022","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MED.0000000000000360","article-title":"Current body composition measurement techniques","volume":"24","author":"T Lemos","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"pone.0336294.ref023","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"VW-S Wong","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"pone.0336294.ref024","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/s0004-2803.201800000-07","article-title":"Measurement of controlled attenuation parameter: a surrogate marker of hepatic steatosis in patients of nonalcoholic fatty liver disease on lifestyle modification - a prospective follow-up study","volume":"55","author":"J Paul","year":"2018","journal-title":"Arq Gastroenterol"},{"issue":"9403","key":"pone.0336294.ref025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"pone.0336294.ref026","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7570\/jomes23031","article-title":"Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity","volume":"32","author":"J-H Haam","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"pone.0336294.ref027","doi-asserted-by":"crossref","first-page":"111846","DOI":"10.1016\/j.diabres.2024.111846","article-title":"Diabetes as a risk factor for MASH progression","volume":"217","author":"S Gancheva","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"pone.0336294.ref028","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.3390\/ijms24119677","article-title":"Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation","volume":"24","author":"R Frankowski","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0336294.ref029","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis","volume":"149","author":"E Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0336294.ref030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"K Promrat","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"pone.0336294.ref031","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.01.005","article-title":"An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans","volume":"27","author":"A Mardinoglu","year":"2018","journal-title":"Cell Metab"},{"issue":"11","key":"pone.0336294.ref032","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/oby.23551","article-title":"Associations between low-carbohydrate and low-fat diets and hepatic steatosis","volume":"30","author":"X Li","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"pone.0336294.ref033","first-page":"483","article-title":"Impact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease","volume":"29","author":"J Chen","year":"2020","journal-title":"Asia Pac J Clin Nutr"},{"issue":"5","key":"pone.0336294.ref034","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.clnu.2018.09.022","article-title":"Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses","volume":"38","author":"J Ahn","year":"2019","journal-title":"Clin Nutr"},{"issue":"12","key":"pone.0336294.ref035","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1111\/liv.14596","article-title":"High-protein diet more effectively reduces hepatic fat than low-protein diet despite lower autophagy and FGF21 levels","volume":"40","author":"C Xu","year":"2020","journal-title":"Liver Int"},{"issue":"12","key":"pone.0336294.ref036","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.3390\/nu13124438","article-title":"Dietary Composition and Its Association with Newly Diagnosed Nonalcoholic Fatty Liver Disease and Insulin Resistance","volume":"13","author":"P Charatcharoenwitthaya","year":"2021","journal-title":"Nutrients"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:31:45Z","timestamp":1764786705000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336294"}},"subtitle":[],"editor":[{"given":"Sophia Eugenia","family":"Mart\u00ednez-V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0336294","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}